ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open Label Study of the Effects of Eculizumab in CD59 Deficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01579838
Recruitment Status : Unknown
Verified April 2012 by Mevorach Dror, Hadassah Medical Organization.
Recruitment status was:  Recruiting
First Posted : April 18, 2012
Last Update Posted : April 18, 2012
Sponsor:
Information provided by (Responsible Party):
Mevorach Dror, Hadassah Medical Organization

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2013
  Estimated Study Completion Date : March 2013